Kempner Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Kempner Capital Management's PFE Position: Q4 2024 in Review
Kempner Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 106,601 shares — an estimated $3.08M sold.
Kempner Capital Management first reported a position in PFE in Q2 2017 and held it in 20 quarters. The position peaked at $3.08M in Q3 2024. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Kempner Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- Kempner Capital Management sold 106,601 Pfizer shares in Q4 2024, an estimated $3.08M.
- Kempner Capital Management first reported a position in Pfizer in Q2 2017 and held it in 20 quarters.
- Kempner Capital Management's Pfizer position peaked at $3.08M in Q3 2024.
- 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Kempner Capital Management's 13F filing for Q4 2024, filed 23 Jan 2025.